Venture
Sonoma Biotherapeutics, Inc.
Latest Form D 2021-08-11- CIK 1877861
- State CA
- Biotechnology
- 1 Form D offering since 2021-08-11
- Total sold
- $265M
- across its one offering
- Rounds
- 1
- Form D offerings since 2021-08-11
- Latest round
- $265M
- 2021-08-11 · 021-409599
- Investors
- 40
- on the latest round
Connected
named in its Form D filingsOfferings · since 2021-08-111 Form D offeringExemptions506(b)People · Item 3Jeffrey Bluestone + 5 moreInvestors · dashboardInferred investors
Sonoma Biotherapeutics, Inc.CIK 1877861
Round timeline
amount sold · by first filed2021-08-11 · $265M
- 2021-08-11$265M021-409599
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($265M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-409599 | First filed2021-08-11 | Latest2021-08-11 | Sought$265M | Sold$265M | Investors40 | Exemptions506(b) |
Who backs Sonoma Biotherapeutics, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2021-08-11
| Name | Relationship |
|---|---|
| Jeffrey Bluestone | RelationshipExecutive Officer, Director, Promoter |
| Richard Klausner | RelationshipDirector |
| Terry Rosen | RelationshipDirector |
| Maggie Wilderotter | RelationshipDirector |
| Toni Hoover | RelationshipDirector |
| Fan Yu | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2021-08-11
- Latest filing
- 2021-08-11
Who backs Sonoma Biotherapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗